Patents by Inventor Ronald W. Davis

Ronald W. Davis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11781187
    Abstract: The present invention provides systems, apparatuses, and methods to detect the presence of fetal cells when mixed with a population of maternal cells in a sample and to test fetal abnormalities, e.g. aneuploidy. The present invention involves labeling regions of genomic DNA in each cell in said mixed sample with different labels wherein each label is specific to each cell and quantifying the labeled regions of genomic DNA from each cell in the mixed sample. More particularly the invention involves quantifying labeled DNA polymorphisms from each cell in the mixed sample.
    Type: Grant
    Filed: November 16, 2018
    Date of Patent: October 10, 2023
    Assignees: The General Hospital Corporation, GPB Scientific, LLC, Verinata Health, Inc.
    Inventors: Daniel Shoemaker, Mehmet Toner, Ravi Kapur, Roland B. Stoughton, Ronald W. Davis
  • Publication number: 20230295691
    Abstract: Provided herein is a circular proximity ligation assay in which proximity-probes are employed as bridges to connect two free oligonucleotides via a dual ligation event, resulting in the formation of a circle. The circles are then quantified by, e.g., qPCR. The addition of an extra oligonucleotide is believed to enhance specificity by decreasing the probability of random background ligation events. In addition, circle formation may have selective advantages, as uncircularized DNA can be removed by a simple exonuclease treatment and it has streamlined the workflow by eliminating preamplification prior to qPCR.
    Type: Application
    Filed: October 27, 2022
    Publication date: September 21, 2023
    Inventors: Henrik H.J. PERSSON, Roxana JALILI, Joseph L. HORECKA, Ronald W. DAVIS
  • Publication number: 20230168160
    Abstract: The present invention provides systems, apparatuses, and methods to detect the presence of fetal cells when mixed with a population of maternal cells in a sample and to test fetal abnormalities, i.e. aneuploidy. In addition, the present invention provides methods to determine when there are insufficient fetal cells for a determination and report a non-informative case. The present invention involves quantifying regions of genomic DNA from a mixed sample. More particularly the invention involves quantifying DNA polymorphisms from the mixed sample.
    Type: Application
    Filed: June 27, 2022
    Publication date: June 1, 2023
    Inventors: Roland Stoughton, Ravi Kapur, Barb Ariel Cohen, Daniel Shoemaker, Ronald W. Davis, Mehmet Toner
  • Patent number: 11530438
    Abstract: Provided herein is a circular proximity ligation assay in which proximity-probes are employed as bridges to connect two free oligonucleotides via a dual ligation event, resulting in the formation of a circle. The circles are then quantified by, e.g., qPCR. The addition of an extra oligonucleotide is believed to enhance specificity by decreasing the probability of random background ligation events. In addition, circle formation may have selective advantages, as uncircularized DNA can be removed by a simple exonuclease treatment and it has streamlined the workflow by eliminating preamplification prior to qPCR.
    Type: Grant
    Filed: February 20, 2018
    Date of Patent: December 20, 2022
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Henrik H. J. Persson, Roxana Jalili, Joseph L. Horecka, Ronald W. Davis
  • Patent number: 11505794
    Abstract: A novel method for preparing sequence-verified oligonucleotides is disclosed. In particular, the invention relates to a simple, affordable, and scalable method that combines high-throughput mating of yeast clones, a unique selectable system for combining DNA sequences in yeast, and next-generation sequencing. This method allows sequence-verified oligonucleotides to be readily isolated from complex libraries.
    Type: Grant
    Filed: August 19, 2020
    Date of Patent: November 22, 2022
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Robert P. St. Onge, Ulrich Schlecht, Sasha F. Levy, Ronald W. Davis, Joseph Horecka
  • Publication number: 20220323960
    Abstract: A heterogeneous population of cells are separated and collected according to a method. The heterogeneous population of cells in a paramagnetic medium are placed in a fluidic channel in which the fluidic channel comprises two or more outlets. The heterogeneous population of cells in the fluidic channel are separated based on differences in magnetic susceptibility and density of the heterogeneous population of cells. Fluid comprising the separated cells is withdrawn from the two or more outlets using variable flow rates by fluidic pumps at respective ones of the two or more outlets simultaneously to fractionalize the fluid comprising the separated cells across the two or more outlets by manipulation of the variable flow rates relative to one another.
    Type: Application
    Filed: April 20, 2022
    Publication date: October 13, 2022
    Inventors: Murat Baday, Naside Gozde Durmus, Semih Calamak, Utkan Demirci, Ronald W. Davis, Lars Steinmetz, Jaeyoung Yang, Thiruppathiraja Chinnasamy, Alessandro Tocchio
  • Patent number: 11378498
    Abstract: The present invention provides systems, apparatuses, and methods to detect the presence of fetal cells when mixed with a population of maternal cells in a sample and to test fetal abnormalities, i.e. aneuploidy. In addition, the present invention provides methods to determine when there are insufficient fetal cells for a determination and report a non-informative case. The present invention involves quantifying regions of genomic DNA from a mixed sample. More particularly the invention involves quantifying DNA polymorphisms from the mixed sample.
    Type: Grant
    Filed: March 16, 2020
    Date of Patent: July 5, 2022
    Assignees: Verinata Health, Inc., The General Hospital Corporation, GPR Scientific, LLC
    Inventors: Roland Stoughton, Ravi Kapur, Barb Ariel Cohen, Daniel Shoemaker, Ronald W. Davis, Mehmet Toner
  • Patent number: 11338290
    Abstract: Systems and methods for levitating populations of moieties, cells, or other such units using one or more magnets in a microfluidic environment are provided. These systems and methods may be used to, for example, separate or sort heterogeneous populations of the units from one another, to assembly a multi-unit assembly during the levitating of the units, and to evaluate samples at the point of care in real-time. These systems and methods may also utilize a frame that enables an imaging device, such as a smartphone, to capture the units in real time as they are manipulated in the system.
    Type: Grant
    Filed: September 30, 2016
    Date of Patent: May 24, 2022
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Murat Baday, Naside Gozde Durmus, Semih Calamak, Utkan Demirci, Ronald W. Davis, Lars Steinmetz, Jaeyoung Yang, Thiruppathiraja Chinnasamy, Alessandro Tocchio
  • Publication number: 20220098640
    Abstract: Systems and methods of performing multiplex PCR on low and ultra-low quantities of starting template using custom primer sequences having a homotag. In some embodiments, these primers are capable of amplifying over 100 targets simultaneously and/or are capable of amplifying targets from low quantities of starting template. Along with these primers, sequencing methods are provided capable of sequencing the targets from numerous individuals, simultaneously. Additionally, methods for analyzing the sequencing results to advance treating an individual are provided.
    Type: Application
    Filed: September 11, 2019
    Publication date: March 31, 2022
    Applicant: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Curt Scharfe, Peidong Shen, Ronald W. Davis
  • Publication number: 20210373037
    Abstract: Magnetic cell levitation and cell monitoring systems and methods are disclosed. A method for separating a heterogeneous population of cells is performed by placing a microcapillary channel containing the heterogeneous population of cells in a magnetically-responsive medium in the disclosed levitation system and separating the cells by balancing magnetic and corrected gravitational forces on the individual cells. A levitation system is also disclosed, having a microscope on which the microcapillary channel is placed and a set of two magnets between which the microcapillary channel is placed. Additionally, a method for monitoring cellular processes in real-time using the levitation system is disclosed.
    Type: Application
    Filed: February 8, 2021
    Publication date: December 2, 2021
    Inventors: Utkan Demirci, Ionita Ghiran, Savas Tasoglu, Ronald W. Davis, Lars Steinmetz, Naside Gozde Durmus, Huseyin Cumhur Tekin
  • Publication number: 20210246440
    Abstract: A novel method for preparing sequence-verified oligonucleotides is disclosed. In particular, the invention relates to a simple, affordable, and scalable method that combines high-throughput mating of yeast clones, a unique selectable system for combining DNA sequences in yeast, and next-generation sequencing. This method allows sequence-verified oligonucleotides to be readily isolated from complex libraries.
    Type: Application
    Filed: August 19, 2020
    Publication date: August 12, 2021
    Inventors: Robert P. St. Onge, Ulrich Schlecht, Sasha F. Levy, Ronald W. Davis, Joseph Horecka
  • Publication number: 20210230678
    Abstract: Methods and apparatus for direct detection of chemical reactions are provided. Electric charge perturbations of the local environment during enzyme-catalyzed reactions are sensed by an electrode system with an immobilized target molecule. The charge perturbation caused by the polymerase reaction can uniquely identify a DNA sequence. The polymerization process generates local perturbations of charge in the solution near the electrode surface and induces a charge in a polarazible gold electrode. This event is detected as a transient current by a voltage clamp amplifier. Detection of single nucleotides in a sequence can be determined by dispensing individual dNTPs to the electrode solution and detecting the charge perturbations. Alternatively, multiple bases can be determined at the same time using a mix of all dNTPs with subsequent analysis of the resulting signal.
    Type: Application
    Filed: November 2, 2020
    Publication date: July 29, 2021
    Inventors: Nader Pourmand, Miloslav Karhanek, Ronald W. Davis
  • Publication number: 20210062261
    Abstract: The present invention provides systems, apparatuses, and methods to detect the presence of fetal cells when mixed with a population of maternal cells in a sample and to test fetal abnormalities, e.g. aneuploidy. The present invention involves labeling regions of genomic DNA in each cell in said mixed sample with different labels wherein each label is specific to each cell and quantifying the labeled regions of genomic DNA from each cell in the mixed sample. More particularly the invention involves quantifying labeled DNA polymorphisms from each cell in the mixed sample.
    Type: Application
    Filed: November 16, 2018
    Publication date: March 4, 2021
    Inventors: Daniel Shoemaker, Mehmet Toner, Ravi Kapur, Roland B. Stoughton, Ronald W. Davis
  • Patent number: 10928404
    Abstract: Magnetic cell levitation and cell monitoring systems and methods are disclosed. A method for separating a heterogeneous population of cells is performed by placing a microcapillary channel containing the heterogeneous population of cells in a magnetically-responsive medium in the disclosed levitation system and separating the cells by balancing magnetic and corrected gravitational forces on the individual cells. A levitation system is also disclosed, having a microscope on which the microcapillary channel is placed and a set of two magnets between which the microcapillary channel is placed. Additionally, a method for monitoring cellular processes in real-time using the levitation system is disclosed.
    Type: Grant
    Filed: February 26, 2015
    Date of Patent: February 23, 2021
    Assignees: The Brigham and Women's Hospital, Inc., The Board of Trustees of the Leland Stanford Junior University, Beth Israel Deaconess Medical Center
    Inventors: Utkan Demirci, Ionita Ghiran, Savas Tasoglu, Ronald W. Davis, Lars Steinmetz, Naside Gozde Durmus, Huseyin Cumhur Tekin
  • Publication number: 20210048426
    Abstract: The present disclosure provides a sensor including a pore and an applied electric field that is capable of detecting analytes such as nucleic acids. In accordance with various embodiments, the sensor comprises a fluidic chamber having electrically opposing portions with a membrane between, the membrane providing a pore suitable for the passage of an electrolyte between the electrically opposing portions of the fluidic chamber, and having at least one charged analyte tethered in proximity to the pore, a first circuit configured to apply an electric field capable of passing the electrolyte through the pore and pulling the at least one charged analyte into the pore, and a second circuit configured to measure a signal indicative of the charge of the at least one charged analyte. Also provided are methods for using the sensor, for example, to sequence a nucleic acid molecule.
    Type: Application
    Filed: April 2, 2020
    Publication date: February 18, 2021
    Applicant: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Kee-Hyun PAIK, Henrik H.J. PERSSON, Billy Tsz Cheong LAU, Hanlee P. JI, Robert W. DUTTON, Yang LIU, Ronald W. DAVIS
  • Publication number: 20210010913
    Abstract: The present invention provides systems, apparatuses, and methods to detect the presence of fetal cells when mixed with a population of maternal cells in a sample and to test fetal abnormalities, i.e. aneuploidy. In addition, the present invention provides methods to determine when there are insufficient fetal cells for a determination and report a non-informative case. The present invention involves quantifying regions of genomic DNA from a mixed sample. More particularly the invention involves quantifying DNA polymorphisms from the mixed sample.
    Type: Application
    Filed: March 16, 2020
    Publication date: January 14, 2021
    Inventors: Roland Stoughton, Ravi Kapur, Barb Ariel Cohen, Daniel Shoemaker, Ronald W. Davis, Mehmet Toner
  • Publication number: 20200377927
    Abstract: A collector device of environmental exposure is provided. This device may be used to collect and, after technical upgrade, monitor environmental exposure in personal and stationary settings. By coupling with advanced genomic analysis and chemical analysis technologies, the device and its accompanying methodology are capable of detecting environmental agents of diverse nature, many of which could pose health risks if going unaware of or uncontrolled. This type of information provides much needed clues to reconstruct and pinpoint the course of disease etiology at both personal and epidemic scales. By combining personal exposome and personal omics analyses, we can recapitulate with the intention to then prescribe treatment plans with unprecedented precision.
    Type: Application
    Filed: April 20, 2018
    Publication date: December 3, 2020
    Inventors: Ronald W. Davis, Jingga Inlora, Chao Jiang, Xiyan Li, Michael Snyder, Ting Wang, Xin Wang
  • Patent number: 10822641
    Abstract: Methods and apparatus for direct detection of chemical reactions are provided. Electric charge perturbations of the local environment during enzyme-catalyzed reactions are sensed by an electrode system with an immobilized target molecule. The charge perturbation caused by the polymerase reaction can uniquely identify a DNA sequence. The polymerization process generates local perturbations of charge in the solution near the electrode surface and induces a charge in a polarazible gold electrode. This event is detected as a transient current by a voltage clamp amplifier. Detection of single nucleotides in a sequence can be determined by dispensing individual dNTPs to the electrode solution and detecting the charge perturbations. Alternatively, multiple bases can be determined at the same time using a mix of all dNTPs with subsequent analysis of the resulting signal.
    Type: Grant
    Filed: April 30, 2018
    Date of Patent: November 3, 2020
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Nader Pourmand, Miloslav Karhanek, Ronald W. Davis
  • Patent number: 10787661
    Abstract: A novel method for preparing sequence-verified oligonucleotides is disclosed. In particular, the invention relates to a simple, affordable, and scalable method that combines high-throughput mating of yeast clones, a unique selectable system for combining DNA sequences in yeast, and next-generation sequencing. This method allows sequence-verified oligonucleotides to be readily isolated from complex libraries.
    Type: Grant
    Filed: October 30, 2015
    Date of Patent: September 29, 2020
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Robert P. St. Onge, Ulrich Schlecht, Sasha F. Levy, Ronald W. Davis, Joseph Horecka
  • Patent number: 10591391
    Abstract: The present invention provides systems, apparatuses, and methods to detect the presence of fetal cells when mixed with a population of maternal cells in a sample and to test fetal abnormalities, i.e. aneuploidy. In addition, the present invention provides methods to determine when there are insufficient fetal cells for a determination and report a non-informative case. The present invention involves quantifying regions of genomic DNA from a mixed sample. More particularly the invention involves quantifying DNA polymorphisms from the mixed sample.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: March 17, 2020
    Assignees: Verinata Health, Inc., The General Hospital Corporation, GPB Scientific, LLC
    Inventors: Roland Stoughton, Ravi Kapur, Barb Ariel Cohen, Daniel Shoemaker, Ronald W. Davis, Mehmet Toner